Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.6884
-0.0246-3.45%
Post-market: 0.68890.0005+0.07%19:48 EDT
Volume:276.30K
Turnover:190.33K
Market Cap:86.84M
PE:-1.22
High:0.7119
Open:0.7044
Low:0.6650
Close:0.7130
Loading ...
Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 03, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 22, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 30, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 21, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 16, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 16, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 14, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 10, 2021

Major Issues Report

8-K - Current report
Jun 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 08, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 07, 2021

Business Combinations

425 - Prospectuses and communications, business combinations